Alexandria Real Estate Equities I.../ US0152711091 /
11/10/2024 22:10:00 | Chg. +2.50 | Volume | Bid00:09:05 | Ask00:09:05 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
117.60USD | +2.17% | 1.25 mill. Turnover: 109.47 mill. |
116.67Bid Size: 100 | 118.12Ask Size: 100 | 20.57 bill.USD | 4.22% | 217.78 |
GlobeNewswire
20/10/2023
SHARC Energy at Forefront of Alexandria’s Sustainable Mega Campus Initiative
GlobeNewswire
21/09/2023
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
GlobeNewswire
23/02/2022
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Th...
GlobeNewswire
21/10/2021
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Ein...
GlobeNewswire
21/09/2021
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footpr...
GlobeNewswire
13/05/2021
TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
29/03/2021
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
GlobeNewswire
24/02/2021
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
GlobeNewswire
12/08/2020
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second ...
GlobeNewswire
14/11/2019
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies